Patents by Inventor Wesley Scott Harper
Wesley Scott Harper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240377383Abstract: The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous glucose sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.Type: ApplicationFiled: July 25, 2024Publication date: November 14, 2024Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Publication number: 20240358919Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.Type: ApplicationFiled: July 5, 2024Publication date: October 31, 2024Inventors: Erwin S. BUDIMAN, Gary A. HAYTER, Nathan C. CROUTHER, Marc B. TAUB, Wesley Scott HARPER, Charles WEI
-
Patent number: 12112854Abstract: Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.Type: GrantFiled: February 21, 2018Date of Patent: October 8, 2024Assignee: ABBOTT DIABETES CARE INC.Inventors: Daniel M. Bernstein, Brittany K. Bradrick, Erwin S. Budiman, Eric Davis, Timothy C. Dunn, Mani Gopal, Wesley S. Harper, Gary A. Hayter, Steve Scott, Todd Winkler, Howard Wolpert
-
Publication number: 20240252076Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: ApplicationFiled: April 16, 2024Publication date: August 1, 2024Applicant: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christain Dunn
-
Publication number: 20240206772Abstract: An analyte monitoring system and method for an on-body sensor control device may have a capability for sensing two or more analytes of a patient includes a processor and memory with instructions for determining various machine states and outputs based on time-correlated sensor data for each of the analytes. The states and outputs may include: an alert condition for one or more analytes; an advisory message; a correction to an analyte state estimate; an indication of a malfunction of the sensor control device, a malfunction of an insulin delivery device, a medication dose calculation; or an analytical report. Examples of the system and method for dual analytes comprising glucose and ketone are described. Data may be transmitted from the sensor control device to a reader device for output to a user.Type: ApplicationFiled: December 21, 2023Publication date: June 27, 2024Inventors: Gary A. Hayter, Erwin S. Budiman, Marc B. Taub, Wesley Scott Harper
-
Publication number: 20230404449Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, receiving the data corresponding to an analyte level, providing a notification on the user interface that comprises a request for a blood analyte measurement, receiving an indication, based on the blood analyte measurement, of an absence of the error condition, and in response to receiving the indication, configuring the user interface to report the data corresponding to the analyte level, where the user interface was previously configured to not report the data corresponding to the analyte level.Type: ApplicationFiled: August 30, 2023Publication date: December 21, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Patent number: 11779248Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.Type: GrantFiled: November 4, 2019Date of Patent: October 10, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Patent number: 11730429Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: GrantFiled: January 20, 2022Date of Patent: August 22, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman, Erich Yen
-
Publication number: 20230066611Abstract: A method of calibrating an analyte measurement system is provided.Type: ApplicationFiled: October 25, 2022Publication date: March 2, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Marc Barry Taub, Wesley Scott Harper, Glenn Howard Berman, Jean Mei Huang
-
Publication number: 20230051983Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: ApplicationFiled: October 31, 2022Publication date: February 16, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Publication number: 20230007916Abstract: The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.Type: ApplicationFiled: July 19, 2022Publication date: January 12, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Publication number: 20230001090Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.Type: ApplicationFiled: September 9, 2022Publication date: January 5, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
-
Publication number: 20220401041Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: August 18, 2022Publication date: December 22, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Patent number: 11484234Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: GrantFiled: June 7, 2022Date of Patent: November 1, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Patent number: 11478173Abstract: A method of calibrating an analyte measurement system is provided.Type: GrantFiled: October 4, 2018Date of Patent: October 25, 2022Assignee: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Wesley Scott Harper, Glenn Howard Berman, Jean Mei Huang
-
Patent number: 11464434Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: GrantFiled: December 20, 2021Date of Patent: October 11, 2022Assignee: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Publication number: 20220296132Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: ApplicationFiled: June 7, 2022Publication date: September 22, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Publication number: 20220287601Abstract: Provided are methods and apparatus for receiving sensor data from an analyte sensor of a sensor monitoring system, processing the received sensor data with time corresponding calibration data, outputting the processed sensor data, detecting one or more adverse conditions associated with the sensor monitoring system, disabling the output of the sensor data during the adverse condition time period, determining that the one or more detected adverse conditions is no longer present in the sensor monitoring system, retrieving the sensor data during the adverse condition time period, processing the retrieved sensor data during the adverse condition time period, and outputting the processed retrieved sensor data.Type: ApplicationFiled: February 28, 2022Publication date: September 15, 2022Inventor: Wesley Scott Harper
-
Publication number: 20220248988Abstract: Improved digital interfaces, graphical user interfaces, and alarms for analyte monitoring systems are provided. For example, disclosed herein are various embodiments of methods, systems, and interfaces for signal loss condition determination, Time-in-Ranges interfaces, GMI metrics, urgent low glucose alarms, alarm suppression features, alarm setup interfaces, and alarm unavailability detection features. In addition, various embodiments of interfaces for alarm logging and compatibility checking of an analyte monitoring software application are described. Also, various embodiments of interface enhancements are described, including an enhanced visibility mode, a voice accessibility mode, additional interfaces relating to user privacy, as well as caregiver alarms, among other embodiments.Type: ApplicationFiled: September 17, 2021Publication date: August 11, 2022Inventors: Panganamala Ashwin Kumar, Jennifer Woo, Stephen A. Rossi, Sujit Jangam, Kendall Covington, Jordan Wing-Haye Lang, Andrew Revoltar, William Koo Lee, Kimberly Hilton, Jeremy Hurwitz, Saranpreet Nagra, Wesley Scott Harper, Swati Satish, Gina Correa, Duncan P. Williams, Naveen Thuramalla, Andreana Dereniak, Justin N. Williams, Marc B. Taub, James P. McCarter, Monica J. Wilkins, Namvar Kiaie, Ismene Grohmann, Laura C. Brandner, Michael L. Bird, Steven Stratis
-
Publication number: 20220240821Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: April 14, 2022Publication date: August 4, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman